E-Cadherin (Epithelial Cadherins) Shows Decreased Expression in Gastric Adenocarcinoma
The answer is (B) Epithelial cadherins - this cell adhesion molecule demonstrates decreased expression in gastric adenocarcinoma cells, particularly in the diffuse histologic subtype, and functions as a tumor suppressor whose loss contributes to cancer progression and metastasis.
Molecular Basis for E-Cadherin Loss
E-cadherin is a critical cell adhesion molecule that maintains epithelial cell-cell contacts and tissue architecture. In gastric adenocarcinoma, loss of E-cadherin expression represents a fundamental molecular alteration that drives malignant transformation 1.
Key Evidence Supporting Decreased E-Cadherin:
Tumor suppressor function: E-cadherin acts as a tumor suppressor in gastric cancer, with its loss associated with increased tumor invasiveness and metastatic potential 1
Hereditary gastric cancer: Germline mutations in CDH1 (the gene encoding E-cadherin) cause hereditary diffuse gastric cancer (HDGC), establishing its critical role in preventing gastric malignancy 2
Histologic correlation: E-cadherin loss is particularly characteristic of diffuse-type gastric adenocarcinoma, one of the two major histologic subtypes 1
Prognostic significance: Reduced E-cadherin expression correlates with poor clinical outcomes and aggressive tumor behavior 1
Why Other Options Are Incorrect
The remaining molecular markers actually show increased (not decreased) expression in gastric adenocarcinoma:
- Type IV collagenase (E): Matrix metalloproteinases that degrade basement membrane are upregulated to facilitate invasion
- Vascular endothelial growth factor (F): Angiogenic factors increase to support tumor vascularization
- Integrins (D): These adhesion molecules often show altered (typically increased) expression patterns
- Cathepsin D (A) and heparin-binding FGF (C): Growth-promoting factors typically increase in malignancy
Clinical Context
In this 82-year-old woman presenting with classic symptoms of gastric cancer (indigestion, bloating, early satiety), the adenocarcinoma cells have undergone malignant transformation characterized by loss of normal epithelial architecture. E-cadherin loss is a hallmark of this process, enabling cancer cells to detach from their neighbors, invade through tissue planes, and metastasize - explaining her progressive symptoms over 7 months.
Molecular Testing Implications
While current guidelines emphasize testing for HER2, MSI/MMR, PD-L1, and CLDN18.2 in gastric adenocarcinoma for therapeutic decision-making 3, E-cadherin status remains fundamental to understanding tumor biology and hereditary cancer risk assessment 2.